Drug Profile
Poliovirus vaccine live - Sanofi
Alternative Names: IMOVAX Polio; Inactivated Polio Vaccine - Sanofi; IPV - Sanofi; OPV - Sanofi; OPV-Merieux; Opvero; Oral Polio Vaccine - Sanofi; Vaccin Antipoliomyelitique/Merieux; Vacina PoliomieliticaLatest Information Update: 08 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Developer Sanofi; sanofi pasteur
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Poliomyelitis
Most Recent Events
- 04 May 2012 No development reported - Phase-II for Poliomyelitis in Philippines (IM)
- 04 May 2012 No development reported - Phase-II for Poliomyelitis in Philippines (Intradermal)
- 03 May 2012 Launched for prevention of Poliomyelitis in Japan (PO)